Roxana Mehran, Usman Baber, Philippe Gabriel Steg, Cono Ariti, Giora Weisz, Bernhard Witzenbichler, Timothy D Henry, Annapoorna S Kini, Thomas Stuckey, David J Cohen, Peter B Berger, Ioannis Iakovou, George Dangas, Ron Waksman, David Antoniucci, Samantha Sartori, Mitchell W Krucoff, James B Hermiller, Fayaz Shawl, C Michael Gibson, Alaide Chieffo, Maria Alu, David J Moliterno, Antonio Colombo, Stuart Pocock
BACKGROUND: Dual antiplatelet therapy (DAPT) cessation increases the risk of adverse events after percutaneous coronary intervention (PCI). Whether risk changes over time, depends on the underlying reason for DAPT cessation, or both is unknown. We assessed associations between different modes of DAPT cessation and cardiovascular risk after PCI. METHODS: The PARIS (patterns of non-adherence to anti-platelet regimens in stented patients) registry is a prospective observational study of patients undergoing PCI with stent implantation in 15 clinical sites in the USA and Europe between July 1, 2009, and Dec 2, 2010...
November 23, 2013: Lancet